Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.
Parnetti L, Reboldi GP, Gallai V. Parnetti L, et al. Among authors: gallai v. Neurology. 2000 Feb 8;54(3):735-7. doi: 10.1212/wnl.54.3.735. Neurology. 2000. PMID: 10680813
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina.
Amici S, Lanari A, Romani R, Antognelli C, Gallai V, Parnetti L. Amici S, et al. Among authors: gallai v. Mech Ageing Dev. 2001 Nov;122(16):2057-62. doi: 10.1016/s0047-6374(01)00314-1. Mech Ageing Dev. 2001. PMID: 11589922
CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group.
Parnetti L, Lanari A, Amici S, Gallai V, Vanmechelen E, Hulstaert F; Phospho-Tau International Study Group. Parnetti L, et al. Among authors: gallai v. Neurol Sci. 2001 Feb;22(1):77-8. doi: 10.1007/s100720170055. Neurol Sci. 2001. PMID: 11487210 Clinical Trial.
Role of neuroprotective drugs in acute ischemic stroke.
Venti M, Parnetti L, Silvestrelli G, Gallai V. Venti M, et al. Among authors: gallai v. Cerebrovasc Dis. 2000;10 Suppl 4:24-6. doi: 10.1159/000047589. Cerebrovasc Dis. 2000. PMID: 11070396 Review. No abstract available.
Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke.
Sarchielli P, Galli F, Floridi A, Floridi A, Gallai V. Sarchielli P, et al. Among authors: gallai v. Amino Acids. 2003 Dec;25(3-4):427-36. doi: 10.1007/s00726-003-0028-6. Epub 2003 Aug 21. Amino Acids. 2003. PMID: 14661102 Review.
A clinical and neurophysiological trial on nootropic drugs in patients with mental decline.
Gallai V, Mazzotta G, Del Gatto F, Montesi S, Mazzetti A, Dominici P, Della Monica A. Gallai V, et al. Acta Neurol (Napoli). 1991 Feb;13(1):1-12. Acta Neurol (Napoli). 1991. PMID: 1867125 Clinical Trial.
Cognitive event-related potential in hepatic encephalopathy.
Gallai V, Alberti A, Balò S, Mazzotta G, Clerici C, Gentili G, Firenze C, Morelli A. Gallai V, et al. Acta Neurol Scand. 1995 May;91(5):358-61. doi: 10.1111/j.1600-0404.1995.tb07021.x. Acta Neurol Scand. 1995. PMID: 7639065
Characteristics of migraine in an out-patient population over 60 years of age.
Mazzotta G, Gallai V, Alberti A, Billeci AM, Coppola F, Sarchielli P. Mazzotta G, et al. Among authors: gallai v. Cephalalgia. 2003 Dec;23(10):953-60. doi: 10.1046/j.1468-2982.2003.00616.x. Cephalalgia. 2003. PMID: 14984227
147 results
Jump to page
Feedback